Thromboprophylaxis rates in US medical centers: success or failure?
- 1 August 2007
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 5 (8), 1610-1616
- https://doi.org/10.1111/j.1538-7836.2007.02650.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Antithrombotic Therapy Practices in US Hospitals in an Era of Practice GuidelinesArchives of Internal Medicine, 2005
- Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized PatientsNew England Journal of Medicine, 2005
- Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis ratesAmerican Journal of Hematology, 2005
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsCirculation, 2004
- Pharmacological thromboembolic prophylaxis in a medical wardJournal of General Internal Medicine, 2002
- Prevention of Venous ThromboembolismChest, 2001
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- The Role of Activated Protein C Resistance in the Pathogenesis of Venous ThrombosisThe American Journal of the Medical Sciences, 1998